ALDOA and Alzheimer disease: The results presented here indicate specific elevation of ALDOA and PKM proteins in AD CSF related to changes in glycolysis, indicating broad dysregulation of glucose metabolism in the AD brain and highlighting both as a potential therapeutic target protein.